"The cancer center's success is not simply a function of establishing a formal relationship among three entities," said longtime CCCC Director Stan Gerson, now also serving as Interim Dean of the School of Medicine. "It involves bringing talented people together, exchanging ideas, and developing new ways to tackle complex challenges. This 10-year extension provides the time and context for us to achieve comparable gains with one another, and also with additional partners."

To that end, the agreement includes commitments from hospital and medical school leaders to engage in regular conversations regarding existing and emerging strategic priorities. In cases where alignment occurs, the organizations would have the opportunity to engage in coordinated investments in research and education.


"We've identified several initial strategic priorities in this renewed commitment to research," said Daniel Simon, MD, Chief Scientific and Clinical Officer for University Hospitals and President of UH Cleveland Medical Center. "Among those priorities are cancer, neuroscience, immunity, imaging and population health. Finally, the extension maintains UH's commitment to provide clinical opportunities for CWRU's medical and allied health students."


SOURCE University Hospitals Cleveland Medical Center

Back to HCB News

U.S. Healthcare Homepage